Virginia Retirement Systems Et Al Clovis Oncology, Inc. Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$1.43 - $3.14 $23,595 - $51,810	-16,500 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$2.7 - $4.76 $38,610 - $68,068	-14,300 Reduced 46.43%	16,500 $45,000
Q3 2021 Oct 21, 2021	SELL	$4.06 - $5.8 $28,825 - $41,180	-7,100 Reduced 18.73%	30,800 $137,000
Q2 2021 Aug 13, 2021	SELL	$5.02 - $7.05 $7,027 - $9,870	-1,400 Reduced 3.56%	37,900 $220,000
Q1 2021 Apr 30, 2021	SELL	$4.81 - $10.34 $449,734 - $966,790	-93,500 Reduced 70.41%	39,300 $276,000
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $548,464 - $851,248	132,800 New	132,800 $637,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.